Journal of Neuro-Oncology

01/15/2025

Kite et al offer a perspective on the role of SRS in spinal metastases from primary prostate cancer originally written by

Read more:

Home Journal of Neuro-Oncology Article Comment on “Stereotactic radiosurgery for patients with spinal metastases from prostate cancer” Correspondence Published: 15 January 2025 (2025) Cite this article Journal of Neuro-Oncology Aims and scope Submit manuscript Trent Kite1, Rodney E. Wegner1,2 & ...

01/14/2025

We are pleased to present our third issue in the JNO of February 2025!

Read more: https://link.springer.com/journal/11060/volumes-and-issues/171-3

01/11/2025

Wach et al. reported the largest meta-analysis of pediatric meningiomas, addressing progression-free survival and overall survival and highlighting the roles of GTR and adjuvant radiotherapy in improving outcomes.

Read more:https://link.springer.com/article/10.1007/s11060-024-04917-7

01/09/2025

Narsinh et al demonstrated CED using liposomal irinotecan was feasible in 18 patients with recurrent high-grade glioma and PFS and OS were higher than expected for this patient population.

Read more: https://ow.ly/k0aE50UCRxU

01/06/2025

Randrian et al. , in the METACER study, showed that brain metastasizes from gastrointestinal cancers have a poor prognosis.

Read more:https://link.springer.com/article/10.1007/s11060-024-04905-x

01/05/2025

El-Hajj et al. reveal that pediatric patients with spinal chordomas often present with more advanced-stage tumors but achieve overall survival outcomes comparable to adults.

Read more:https://link.springer.com/article/10.1007/s11060-024-04921-x

01/03/2025

Editorial board member spotlight:

Dr. Kamran Ahmed is an Associate Vice Chair of Research . He is the PI of several multicenter trials in the management of brain metastases and leptomeningeal disease with novel therapeutics and radiation therapy.

01/03/2025

We are pleased to present our second of two issues in the JNO for January of 2025!

Read more: https://link.springer.com/journal/11060/volumes-and-issues/171-2

01/03/2025

Shoshan et al. reported the safety and feasibility of implementing alpha-emitter radiation therapy (Alpha-DaRT) in swine brains using image-guided stereotactic.

Read more:https://link.springer.com/article/10.1007/s11060-024-04919-5

12/31/2024

Godinez et al underscore the importance of a multidirectional approach in chordoma treatment throughout the disease progression to reduce morbidity and improve patient outcomes.

Read more: https://link.springer.com/article/10.1007/s11060-024-04920-y

12/27/2024

Chen et al. compared MR perfusion characteristics of pseudoprogression in brain tumors treated with immunotherapy with pseudoprogression after chemo-radiation and radiation necrosis after radiation.

Read more:https://link.springer.com/article/10.1007/s11060-024-04910-0

12/24/2024

Vanderheijden et al. showed that the differential expression of chordin, HOXA5, ACAN, and CD24 could be relevant for the pathophysiology of chordomas and may have diagnostic and treatment value.

Read more:https://link.springer.com/article/10.1007/s11060-024-04913-x

12/22/2024

Obara et al. assessed the quality of life of patients with diffuse low-grade glioma and showed significantly lower cognitive, emotional, role, and social functioning than the normative population.
Read more:https://link.springer.com/article/10.1007/s11060-024-04888-9

12/19/2024

Grewal et al demonstrated in an excellent review article that the rapid evolution of investigational CAR T cell therapies portends great potential for the future of glioma treatment.

Read more: https://ow.ly/Ym5850Uu4He

12/18/2024

Taori et al. reviewed the transformative potential of circulating biomarkers in managing high-grade glioma, with implications for real-world clinical practice.



Read more: https://link.springer.com/article/10.1007/s11060-024-04903-z

12/17/2024

Mondia et al. reported the first case of GBM presenting exclusively as LMD without a primary lesion and provided diagnostic and therapeutic recommendations.

Read more: https://link.springer.com/article/10.1007/s11060-024-04908-8

12/12/2024

We are pleased to present our latest newsletter. We have highlighted a few of the many accomplishments the journal has achieved in 2024!

Link:

Welcome to the Journal of Neuro-Oncology newsletter for 2024. In this newsletter, we would like to share with you some journal highlights and current developments for Journal of Neuro-Oncology.

12/12/2024

In order to show additional support for the European Association for Cancer Research future conference we are sharing a link to the conference webpage for more details! A great opportunity!

https://ow.ly/bN5w50Uq8N1